Previous close | 1,523.50 |
Open | 1,525.00 |
Bid | 1,554.00 x 0 |
Ask | 1,555.00 x 0 |
Day's range | 1,521.50 - 1,669.26 |
52-week range | 1,330.19 - 1,823.50 |
Volume | |
Avg. volume | 7,840,933 |
Market cap | 63.334B |
Beta (5Y monthly) | 0.30 |
PE ratio (TTM) | 14.25 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 0.60 (3.86%) |
Ex-dividend date | 16 May 2024 |
1y target est | N/A |
PHILADELPHIA, July 11, 2024--GSK plc (LSE/NYSE: GSK) today announced it has started shipping doses of its trivalent influenza vaccines to US healthcare providers and pharmacies in preparation for the 2024-25 flu season. This immediately follows a licensing and lot-release approval from the US Food and Drug Administration (FDA).
PHILADELPHIA, June 07, 2024--US FDA approves expanded age indication for GSK’s AREXVY, the first respiratory syncytial virus (RSV) vaccine for adults aged 50-59 at increased risk
PHILADELPHIA, June 03, 2024--Jemperli trial continues to show unprecedented results with no evidence of disease in 100% of patients with locally advanced dMMR rectal cancer